Pharma Microbiology Congress 25 Insights – Focus on Rapid Microbiology Methods (Session 2 & 6)
- On demand
- Online
English
- On demand
- Online
-
English
Training overview
Following the enthusiastic feedback received from attendees of the three-day event, PEC is pleased to make available a selection of recorded virtual sessions. This initiative aims to give professionals in pharmaceutical microbiology—especially those who could not attend in person—the opportunity to access key discussions and valuable insights shared during the congress.
The Scientific Board has selected the sessions dedicated to Rapid Microbiological Methods (RMM), specifically Sessions 2 and 6, recognizing their high relevance and timeliness. These sessions stand out for the diversity of expert perspectives and practical case studies presented, made possible also through collaboration with Bioforum. They feature contributions from a PEI assessor and include an overview of the latest pharmacopoeial regulatory updates, providing a comprehensive view of current trends and future directions in RMM.
Gain access to these exclusive recordings and stay up to date with the latest developments shaping the future of rapid microbiology.
METHODOLOGY: The extract will be delivered via recording. The participant will receive a link to access the platform, where the content will remain available for 2 days from the date of delivery.
Key points of the training
- SESSION 2 - Rapid Microbiological Methods (RMMs) are becoming a regulatory expectation and a strategic imperative for sterile manufacturers, representing essential tools for enhancing the Sterility assurance. Authorities like the EMA and FDA are encouraging the adoption of RMMs, provided they are properly validated. The session will explore the RMM’s journey that industries are addressing among regulatory requirements, advanced technologies and culture shift.
- SESSION 6 - This focus will provide an overview of the regulatory landscape for alternative methods, offering an opportunity to delve into the expectations of authorities for the implementation of these new technologies.
Program
SESSION 2 – INDUSTRY’S JOURNEY TOWARDS RAPID METHODS: PERSPECTIVES AND APPLICATIONS
Introduction by the Chairperson
Alice Le Gatt, Global Change Facilitator | BioPhorum
Industry’s Journey towards Rapid Microbiological Methods: A BioPhorum Perspective
Alice Le Gatt, Global Change Facilitator | BioPhorum
Caitlin Cooke, Scientist, Global Product Development, Pharmaceutical Technology and Development | AstraZeneca
Project Management and Validation Strategy of Growth Direct System for Environmental Monitoring and Water-Bioburden
Miriam Meinersmann, Expert GMP Compliance and Documentation Microbiology and Monitoring Quality Control | Daiichi Sankyo Europe GmbH, Germany
Franziska Graf, Trainee Microbiology and Monitoring Quality Control | Daiichi Sankyo Europe GmbH, Germany
Implementation roadmap of OWBA in Pharma, with use-case of implementing enzyme activity-based OWBA on PW/WFI
Sebastian Strandberg Rutell, Associate Process Engineer in PAT | Novo Nordisk
Regulatory Focus by PEI
Oleg Krut, Head of Microbial Safety Department | Paul-Ehrlich-Institut (PEI)
Round Table
Moderator: A. Le Gatt
Participants: C. Cooke, F. Graf, O. Krut, M. Meinersmann, S. Strandberg Rutell, Johannes Oberdorfer | Rapid Micro Biosystems, Allison Scott | Member of Modern Microbial Methods (M3) Collaboration
SESSION 6 – KEY CONSIDERATIONS – Regulatory requirements for Alternative Methods: adoption & implementation
Focus on Ph. Eur. 5.1.6. commenting phase and USP <1071>, <72> and <73> updated release
Lucia Ceresa, Freelance Pharmaceutical Consultant & PDA Italy Chapter Board
Q&A Time
Lucia Ceresa, Freelance Pharmaceutical Consultant & PDA Italy Chapter Board
Pharma, Biotech and Medical Device Companies, Regulatory bodies and Technology Suppliers involved in the manufacturing and control of Sterile medicines.
The course will be carried out through live lectures. Practical examples will be showcased, providing delegates with real life examples to be applied in their daily job life.
For online trainings the access link will be sent 2-3 days before the start of the training.
5% discount for registrations within 1 month before the start of the training, 10% discount for registrations within 2 months before the start of the training. VAT not included. Please inquire for discounts for multiple registrations. Discounts are not cumulative.
Cancellation terms
In order to cancel enrolment to an event, please email info@pharmaeducationcenter.it within 2 weeks before the starting date of the event. Once this term will be expired, the entire fee will be charged.
Participant replacement
It is possible to replace a participant attendance without additional cost, simply by contacting info@pharmaeducationcenter.it. It is asked to notify the participant replacement request within 5 days before the starting date of the course/event, specifying the full name and surname of the enrolled participant as well as the full name and surname of the substitute.
Training cancellation
If the minimum number of participants is not reached, Pharma Education Center reserves the right to cancel or schedule the event for another date. Formal communication will be given within 5 days before the event date. In this case Pharma Education Center will refund the registration fee in full and without additional charges. Alternatively, the participant can request a spendable coupon for participating in another PEC event scheduled in the current year.
Speakers

Lucia Ceresa
Freelance Pharmaceutical Consultant & PDA Italy Chapter Board
PDA Italy Chapter Board

Caitlin Cooke
Scientist, Global Product Development, Pharmaceutical Technology and Development
AstraZeneca

Franziska Graf
Trainee Microbiology and Monitoring Quality Control
Daiichi Sankyo Europe GmbH, Germany

Oleg Krut
Head of Microbial Safety Department
Paul-Ehrlich-Institut (PEI)

Alice Le Gatt
Global Change Facilitator
BioPhorum

Miriam Meinersmann
Expert GMP Compliance and Documentation Microbiology and Monitoring Quality Control
Daiichi Sankyo Europe GmbH, Germany

Johannes Oberdorfer
Field Application Scientist
Rapid Micro Biosystems

Allison Scott
Principal Scientist
BWT Pharma & Biotech Inc

Sebastian Strandberg Rutell
Associate Process Engineer in PAT
Novo Nordisk
Register now
300€
Training materials available for attendees
Certificate of attendance
Senior trainers with hands-on experience
You may also be interested in...
- 26 Febbraio 2026
- Online
- 2 March 2026
- Online
- 3 Marzo 2026
- Online
- 11 Marzo 2026
- Online
Il Regolamento (UE) 1924/2006 disciplina le indicazioni nutrizionali e sulla salute fornite sui prodotti alimentari. Tale normativa si applica a [...]
- NEW
- 12 March 2026
- Online
- NEW
- 9 Aprile 2026
- Online
- NEW
- 14 Aprile 2026
- Online
- NEW
- TBC
- Online
- 20 Aprile 2026
- Online
- PROMO
- 21 Aprile 2026
- Online
- NEW
- 5-6 Maggio 2026
- Online
- 26 May 2026
- Online